JPRN-UMIN000031823已完成未知
A phase II trial evaluating the effect of olanzapine 5mg for breakthrough nausea and vomiting in patients receiving carboplatin based chemotherapy - The trial of olanzapine 5mg for breakthrough nausea and voimiting
Aichi Cancer Center Hospital0 个研究点目标入组 84 人开始时间: 2018年3月21日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 84
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Patients who has history of hypersensitivity or allergy for study drugs or similar compounds. (2) Patients who do not have enough whole body state to the antineoplastic agents treatment (3) Patient undergoing diabetes treatment (4) Patients with symptomatic brain metastasis (5) Patients who has a convulsive disorders that need anticonvulsants therapy. (6) Patients with symptomatic ascites that need therapeutic drainage. (7) Pregnant, breastfeeding or expecting woman, or patients without intention to contraception (8) Patients enforced radiotherapy on the period between 6 days before and 6 days after of the date of first therapy. (9) Patients who are using prophylactic antiemetic therapy drugs other than NK1 receptor antagonist, 5HT3 antagonist or dexamethasone. (10) Patients who take a medicine regularly antidopamine agonists, phenothiazine tranquilizers,antihistamine drugs, benzodiazepine,agents. (11) Judged by the investigator to be inappropriate for this study (12) Patients who has nausea at the start of chemotherapy (13) Patients who started opioids within 1 week of chemotherapy
研究者
相似试验
尚未招募
3 期
Olanzapine in pediatric chemotherapy induced nausea and vomiting iIRCT20120415009475N14Vice Chancellor for research of Shahid Beheshti University of Medical Sciences56
已完成
2 期
A double-blind randomized phase II study of olanzapine 10mg versus 5mg for highly emetogenic chemotherapy-induced nausea and vomiting.Malignant solid tumorJPRN-UMIN000014214ational Cancer Center Hospital150
尚未招募
不适用
A randomized phase II clinical trial of talazoparib maintenance therapy in triple-negative breast cancer patients who showed platinum-sensitivity on first- or second-line platinum-based chemotherapyKCT0005671Yonsei University Health System, Severance Hospital206
招募中
2 期
A phase II trial of evaluating the benefit of zoledronic acid in non-small cell lung cancer patients with bone metastases and elevated marker of osteoclast activity.on-small cell lung cancer patients with bone metastases and elevated marker of osteoclast activityJPRN-UMIN000005088ung Oncology Group in Kyushu, Japan (LOGIK)55
招募中
3 期
Investigating the effect of prescribing olanzapine on reducing the amount of midazolam and fentanyl and preventing deliriumIRCT20240319061337N1Ilam University of Medical Sciences72